A potentially relevant hypothesis in this context is that the relative strength of activation of the IRF3 versus NF-kB downstream signaling arms may impact anti-tumor activity versus tumorigenic and tolerability issues30,31. This evidence concerns the gene NFKB1 and neoplasm.